Logo
DCA

Repligen Corporation

RGENHealthcareMedical Instruments & Supplies
121,13 $US
-1.60%
Dernier cours
121,13 $US
2026-06-02
Variation 24h
-1.60%
-1.97 USD
Volume
738 k
Titres échangés
Fiabilité des données
Forte
10101 points (40 ans)

Évolution du cours

Lancer une simulation avec cet actif

RGEN

Paramètres globaux

Données disponibles du 29/04/1986 au 02/06/2026

Analyse Fondamentale

New
CAGR (5y)
-2.70%
Revenue Growth
Net Margin
6.62%
Profitability
ROE
2.32%
Return on Equity
Debt / EBITDA
3.81
Solvency
PEG Ratio
1.63
Valuation vs Growth
Rev. Growth (TTM)
14.80%
Current Trend

Historique PER (5 ans)

Historical PE
Average (135.9x)
Current: 114.5x
Focus technique
RGEN
Volatilité 30j
74.92%
Écart MA50
2.44%
Écart MA200
-12.08%
Écart ATH
-62.64%
Momentum 3M
-3.74%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR6.11%
Volatilité74.92%
Max Drawdown-50.64%

Momentum : RGEN

Indicateur synthétique
PEURNEUTREAVIDITÉ
40
Fear

Analyse Risque

VaR (95%)-6.45%
Santé DCA
60/100

Historique récent (60 jours)

DateClôtureVolume
2026-06-02121,13 $US737 914
2026-06-01123,10 $US654 931
2026-05-29123,95 $US823 724
2026-05-28122,73 $US1 425 481
2026-05-27113,17 $US1 125 500
2026-05-26115,19 $US787 000
2026-05-22115,06 $US714 436
2026-05-21113,37 $US990 913
2026-05-20111,74 $US1 164 132
2026-05-19108,52 $US2 199 779
2026-05-18104,20 $US1 547 665
2026-05-15102,87 $US2 307 248
2026-05-14103,38 $US2 010 732
2026-05-13107,03 $US1 660 291
2026-05-12113,60 $US1 454 864
2026-05-11115,91 $US1 283 636
2026-05-08123,46 $US924 244
2026-05-07126,43 $US935 806
2026-05-06125,76 $US1 625 385
2026-05-05125,61 $US2 065 504
2026-05-04118,21 $US1 280 562
2026-05-01117,20 $US751 851
2026-04-30118,31 $US1 609 810
2026-04-29113,11 $US852 039
2026-04-28117,43 $US726 060
2026-04-27118,29 $US779 099
2026-04-24117,60 $US1 234 335
2026-04-23114,06 $US2 165 393
2026-04-22124,40 $US1 016 244
2026-04-21132,70 $US1 086 726
2026-04-20131,99 $US675 203
2026-04-17131,21 $US1 122 130
2026-04-16127,09 $US620 933
2026-04-15131,93 $US810 918
2026-04-14131,03 $US1 184 340
2026-04-13122,59 $US745 757
2026-04-10120,10 $US532 309
2026-04-09119,78 $US587 844
2026-04-08119,77 $US730 218
2026-04-07115,29 $US633 397
2026-04-06116,95 $US557 545
2026-04-02117,78 $US784 691
2026-04-01118,32 $US1 103 774
2026-03-31117,82 $US1 284 049
2026-03-30111,49 $US625 944
2026-03-27110,12 $US797 926
2026-03-26114,42 $US710 452
2026-03-25114,32 $US1 265 751
2026-03-24116,30 $US403 004
2026-03-23116,35 $US808 050
2026-03-20113,88 $US859 375
2026-03-19117,61 $US606 542
2026-03-18117,59 $US801 234
2026-03-17119,27 $US1 250 399
2026-03-16115,11 $US828 563
2026-03-13114,20 $US1 099 079
2026-03-12113,76 $US1 366 590
2026-03-11119,23 $US1 086 288
2026-03-10121,79 $US1 155 900
2026-03-09127,89 $US1 118 757

Actifs Relatifs